Total Funding
62
16
Total FundingPrivate Equity raised
Growth Score 62 in past quarter
-6 pts
Heat Score 16 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1346005
Novalere FP is a consumer healthcare company developing and commercializing differentiated non-prescription products.
Acquired by 
Innovus Pharmaceuticals
- Steve Howard: VP, MarketingPast Role: Schering-Plough, Senior Director
- John M. Clayton: SVP, Scientific & Regulatory AffairsPast Role: Schering-Plough, SVP, Scientific and Regulatory Affairs - Schering-Plough HealthCare Products
About the Company
The evolving healthcare environment has created an expanding need for safe and efficacious product options as consumers take greater control of their own health. Founded in 2012 to fill this need, Novalere is a consumer healthcare company focused on discovering, developing and commercializing differentiated nonprescription products that have a
well-documented track record of both efficacy and safety.

